Agree that in the published paper EOLS is reverting to the (bad) norm of plotting the time to reversion to baseline for *only* those patients who have previous responded to the neuromod. (Ie The KM curves start at 100%). This makes the graphs non comparable to Daxxy - and thus was stupid as a mechanism to compare to Daxxy (which is a more honest ITT).
That said, this appears to be the same data as in below link, and in that data, in an Apple to Apple comparison EOLS looks arguably as good as Daxxy..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.